Save the date for the
2027 Crohn’s & Colitis Congress®
Step into the future of inflammatory bowel disease (IBD) care at the 10th anniversary Crohn’s & Colitis Congress®—where the brightest minds in IBD come together to shape what’s next.
Join the Crohn’s & Colitis Foundation and the American Gastroenterological Association in New Orleans, January 21–23, 2027, as we celebrate a decade of collaboration, discovery, and progress—and set the stage for the next era of breakthroughs.
For 10 years, the Crohn’s & Colitis Congress has been the place where the IBD community comes together to learn, collaborate, and lead. In 2027, we’re bringing that energy to New Orleans, for our most exciting Congress yet.
Experience three days of breakthrough science, real-world clinical insights, and interactive learning designed to challenge your thinking and elevate your practice. From emerging therapies to multidisciplinary care strategies, every session is built to help you deliver better outcomes for your patients.
Connect with colleagues across specialties, exchange ideas with leaders in the field, and be part of the conversations shaping the future of IBD.
Don’t just keep up with what’s next—be part of it. We look forward to seeing you in New Orleans!
On behalf of the Crohn’s & Colitis Foundation and the American Gastroenterological Association, thank you to all our 2026 attendees, Congress Chairs, faculty, industry supporters, exhibitors, and partners. Your energy, expertise, and collaboration made this year’s Congress an exceptional gathering of the IBD community.
Together, we explored the latest breakthroughs, shared real‑world clinical insights, and strengthened the multidisciplinary connections that drive better outcomes for people living with inflammatory bowel diseases. Your participation is what fuels the progress and purpose of this Congress each year.
Looking Ahead: Join Us in New Orleans, January 21–23, 2027
We are thrilled to announce that the 2027 Crohn’s & Colitis Congress® will take place in New Orleans, January 21–23, 2027.
As we return with fresh content, deeper clinical learning, and expanded opportunities to learn, connect, and collaborate, we invite you to be part of another transformative experience. Stay tuned for program updates, registration details, and ways to get involved.
Why You Should Attend the Crohn’s & Colitis Congress
Drs. Allegretti, Edelblum, and Ha reveal why they are excited to bring you the 2026 Congress.
Upcoming Dates
Marriott Marquis Hotel Deadline Extension: Wednesday, January 29, 2025
Standard Registration Deadline: Wednesday, February 5, 2025
Important Upcoming Dates
Registration
Registration Opens: Wednesday, July 22, 2026
Early Registration Deadline: Wednesday, September 9, 2026
Advanced Registration Deadline: Wednesday, October 28, 2026
Discounted Registration Deadline: Wednesday, December 9, 2026
Hotel Reservation Deadline: Friday, December 18, 2026
Standard Registration Deadline: Tuesday, January 19, 2027
Abstract Submission
Abstract Submission Opens: Wednesday, August 12, 2026
Abstract Submission Deadline: Wednesday, September 23, 2026
Abstract Notification: Friday, November 20, 2026
Abstract Acceptance Deadline: Wednesday, November 25, 2026
Registration
Registration Opens: Wednesday, July 23, 2025
Early Registration Deadline: Tuesday, September 2, 2025
Advanced Registration Deadline: Tuesday, October 21, 2025
Discounted Registration Deadline: Tuesday, December 9, 2025
Hotel Reservation Deadline: Thursday, December 18, 2025
Standard Registration Deadline: Tuesday, January 20, 2026
2027 Crohn's & Colitis Congress Chairs
Shrinivas Bishu, MD
Co-Chair, Organizing Committee
University of Michigan
Arianne L. Theiss, PhD, AGAF
Co-Chair, Organizing Committee
University of Colorado Anschutz Medical Campus
Andres J. Yarur, MD, AGAF
Co-Chair, Organizing Committee
Cedars-Sinai Medical Center
Supporting Organization
The 2025 Crohn’s & Colitis Congress® was supported by an educational grant from:
Ferring Pharmaceuticals, Inc.
Lilly
Pfizer
Takeda Pharmaceuticals U.S.A., Inc.
Salix Pharmaceuticals, Inc.
Bristol Myers Squibb
AbbVie Inc.
Salix Pharmaceuticals, a division of Bausch Health US, LLC
Pfizer Inc.
Takeda Pharmaceuticals U.S.A., Inc.
Recognition
The 2026 Crohn’s & Colitis Congress® partnered with:
Media Partners
Special thanks to our 2026 Crohn’s & Colitis Congress® media partners:
